Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Tr1x is a biotechnology company developing novel cellular immunotherapies for patients with autoimmune and inflammatory diseases.
NILO Therapeutics is a biotechnology and therapeutics company.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Exonics Therapeutics, a Boston, Mass.-based biotechnology company.
Seragon Pharmaceuticals is a research-based company dedicated to improving human and animal health through innovative science.
Cyterix Pharmaceuticals is a cancer therapeutics company developing small molecule prodrugs.
The Column Group has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
The Column Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Surrozen received $175.0M in a Post Ipo Equity round. The Column Group's total known invested capital is $3.9B.
The Column Group's average investment size is $95.2M across its portfolio of 42 companies.
Recent The Column Group portfolio additions include Casma Therapeutics, Atavistik Bio, InduPro, Kenai Therapeutics, Tr1x. These companies were founded in 2020 or later.